Ayrton Drugs Manufacturing Company Ltd. reported unaudited financial results for the third quarter ended March 31, 2018. For the quarter, the company reported operating profit of GHC 3,404,080, profit before tax of GHC 2,077,236 and profit after tax of GHC 1,603,702 on revenue of GHC 26,945,467 against operating profit of GHC 4,753,868, profit before tax of GHC 3,120,794 and profit after tax of GHC 3,120,794 on revenue of GHC 27,113,709 for the same period of last year.